News & Updates

Show Multimedia Only

RE-BUILD app offers self-monitoring aid to ILD patients

28 Feb 2025

A novel smartphone application (app) has demonstrated its usability for self-monitoring and data collection in patients with interstitial lung disease (ILD), reports a study.

RE-BUILD app offers self-monitoring aid to ILD patients

28 Feb 2025

Lung function a potential biomarker for glaucoma

28 Feb 2025 by

Lung function measures are associated with risk of glaucoma, indicating their potential role as biomarkers for the optic neuropathy with a devastating visual impact, researchers from the Chinese University of Hong Kong, Princes of Wales Hospital and Hong Kong Eye Hospital have reported.

Lung function a potential biomarker for glaucoma

28 Feb 2025

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

26 Feb 2025 by

A 70-year-old female has a history of adult-onset asthma managed with a moderate-dose budesonide/formoterol inhaler. In 2019, she presented with skin rash and neuropathy (numbness). Complete blood counts showed elevated absolute eosinophil, peaking at 6,000 cells/μL. In conjunction with skin biopsy and nerve conduction studies, the diagnosis of hypereosinophilic syn¬drome (HES) was made.

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

26 Feb 2025

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

25 Feb 2025 by

Neither SARS-CoV-2 infection exposure nor COVID-19 vaccination during pregnancy poses a significant risk to early child development, as shown in a population-level study said to be the largest to date.

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

25 Feb 2025

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

19 Feb 2025 by

In adults with type 2 diabetes and active chronic obstructive pulmonary disease (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also reduce the risk of COPD exacerbations, according to a study.

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

19 Feb 2025

Achieving clinical remission in severe asthma: What’s new in Asian population?

14 Feb 2025 by

Associated eosinophilic inflammation, plays a crucial role in the pathogenesis of severe asthma, current standard-of-care management may not adequately address this important pathogenic contributor. At the 28^th Congress of the Asian Pacific Society of Respirology, Professor Ian Pavord from the University of Oxford, UK, discussed how early treatment of underlying inflammation in asthma with biologics, such as the anti–IL-5 biologic mepolizumab, may facilitate clinical remission and improve patient outcomes, especially in the Asian population. Dr Ken Chan from the Chinese University of Hong Kong highlighted the unique characteristics of Asian asthma patients and emphasized the importance of phenotyping in guiding use of biologics.

Achieving clinical remission in severe asthma: What’s new in Asian population?

14 Feb 2025

Rezivertinib bests gefitinib in first-line treatment of advanced EGFR-mutant NSCLC

14 Feb 2025

In the first-line treatment of patients with EGFR-mutated locally advanced or metastatic non–small-cell lung cancer (NSCLC), the novel third-generation EGFR tyrosine kinase inhibitor rezivertinib yields superior overall efficacy and progression-free survival (PFS) when compared with gefitinib, with no new safety signals, according to the phase III REZOR trial.

Rezivertinib bests gefitinib in first-line treatment of advanced EGFR-mutant NSCLC

14 Feb 2025

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

06 Feb 2025

All biologic classes—anti-IgE, anti-IL5/R, and anti-IL4R—help improve outcomes in patients with severe allergic asthma with nasal polyps treated in real-world settings, according to a study. However, anti-IL4R bests the other two in terms of improving the smell, nasal obstruction, and nasal polyp endoscopic size.

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

06 Feb 2025

Age, ventilation impact extubation outcomes in preemies

05 Feb 2025

The likelihood of extubation failure in preterm neonates is high among those with lower gestational and chronological age and higher levels of pre-extubation ventilation support, according to the results of a systematic review and meta-analysis.

Age, ventilation impact extubation outcomes in preemies

05 Feb 2025

Which factors predict treatment initiation among individuals with negative TB result?

31 Jan 2025 by

Several factors, including male sex and reported cough, influence the decisions by clinicians to initiate tuberculosis (TB) treatment among individuals who receive a negative result on an initial bacteriological test for TB, reports a study.

Which factors predict treatment initiation among individuals with negative TB result?

31 Jan 2025

News & Updates

Filter by Specialty:

Specialty:

RE-BUILD app offers self-monitoring aid to ILD patients

RE-BUILD app offers self-monitoring aid to ILD patients

Lung function a potential biomarker for glaucoma

Lung function a potential biomarker for glaucoma

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

SGLT-2is, GLP-1RAs cut risk of COPD flare-ups

Achieving clinical remission in severe asthma: What’s new in Asian population?

Achieving clinical remission in severe asthma: What’s new in Asian population?

Rezivertinib bests gefitinib in first-line treatment of advanced EGFR-mutant NSCLC

Rezivertinib bests gefitinib in first-line treatment of advanced EGFR-mutant NSCLC

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

Three biologic classes beneficial for severe allergic asthma with nasal polyps in real world

Age, ventilation impact extubation outcomes in preemies

Age, ventilation impact extubation outcomes in preemies

Which factors predict treatment initiation among individuals with negative TB result?

Which factors predict treatment initiation among individuals with negative TB result?